|
|
|
|
| LEADER |
00840nam a2200253 a 4500 |
| 001 |
adlib96000001 |
| 003 |
ViArRB |
| 005 |
20151026131922.0 |
| 008 |
960221s1955 dcuabcdjdbkoqu001 0deng d |
| 020 |
|
|
|a 92-4-154547-X
|
| 022 |
|
|
|
| 040 |
|
|
|a Adlib
|
| 082 |
|
|
|a 615.012
|
| 245 |
|
|
|a How to develop and implement a national drug policy
|
| 250 |
|
|
|a 2nd. ed.
|
| 260 |
|
|
|a Geneva
|b World Health Organisation
|c 2001
|
| 300 |
|
|
|a viii,83p.
|
| 500 |
|
|
|a Updates and replaces guidelines for developing national drug policies,1988
|
| 100 |
|
|
|
| 700 |
|
|
|
| 942 |
|
|
|c BK
|6 _
|
| 653 |
|
|
|a Essential drugs- standards
|a DRUG AND NARCOTIC CONTROL
|a Drug utilization- standards
|a Legislation, Drug
|a Guidelines
|
| 999 |
|
|
|c 38097
|d 38097
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615012_WHO
|7 0
|9 49879
|a UL
|b UL
|d 2010-06-16
|o 615.012 WHO
|p G0008089
|r 2010-06-16
|w 2010-06-16
|y BK
|